long acting beta agonist/long acting muscarinic agonist (AeroRx Therapeutics)

N/A

Report date: 2025/06/11 10:20:56
NME

Base Information

Drug Namelong acting beta agonist/long acting muscarinic agonist (AeroRx Therapeutics)
Drug Alias NameLABA + LAMA solution (AeroRx Partners)
ClassificationSmall molecules
Mechanisms of ActionBeta adrenergic receptors agonistsMuscarinic acetylcholine receptor agonists
TargetsBeta adrenergic receptorsMuscarinic acetylcholine receptor
Therapy Area/IndicationsPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesiPharma Labs Inc
China Registration ClassN/A

Develop Information

Active CompaniesAeroRx Partners
Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic Obstructive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A